Caplacizumab use for immune thrombotic thrombocytopenic purpura: the Milan thrombotic thrombocytopenic purpura registry.
Res Pract Thromb Haemost
; 7(6): 102185, 2023 Aug.
Article
em En
| MEDLINE
| ID: mdl-37720483
ABSTRACT
â¢Data on caplacizumab use for thrombotic thrombocytopenic purpura (TTP) in Italy are missing.â¢Twenty-six Italian patients were treated with caplacizumab for an acute immune TTP episode.â¢Caplacizumab was effective in treating acute TTP in the Italian real-world clinical setting.â¢Two major bleeds leading to drug discontinuation were observed.
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Revista:
Res Pract Thromb Haemost
Ano de publicação:
2023
Tipo de documento:
Article
País de afiliação:
Itália